96 related articles for article (PubMed ID: 9078530)
1. The angiogenesis inhibitor TNP-470 reduces the growth rate of human neuroblastoma in nude rats.
Wassberg E; Påhlman S; Westlin JE; Christofferson R
Pediatr Res; 1997 Mar; 41(3):327-33. PubMed ID: 9078530
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of angiogenesis induces chromaffin differentiation and apoptosis in neuroblastoma.
Wassberg E; Hedborg F; Sköldenberg E; Stridsberg M; Christofferson R
Am J Pathol; 1999 Feb; 154(2):395-403. PubMed ID: 10027398
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of the angiogenesis inhibitor TNP-470 in reducing the growth of human neuroblastoma in nude mice inversely correlates with tumor burden.
Katzenstein HM; Rademaker AW; Senger C; Salwen HR; Nguyen NN; Thorner PS; Litsas L; Cohn SL
Clin Cancer Res; 1999 Dec; 5(12):4273-8. PubMed ID: 10632370
[TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic therapy inhibits human neuroblastoma growth.
Katzenstein HM; Salwen HR; Nguyen NN; Meitar D; Cohn SL
Med Pediatr Oncol; 2001 Jan; 36(1):190-3. PubMed ID: 11464880
[TBL] [Abstract][Full Text] [Related]
5. Angiostatic treatment of neuroblastoma.
Wassberg E; Christofferson R
Eur J Cancer; 1997 Oct; 33(12):2020-3. PubMed ID: 9516846
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of TNP-470 on hepatic metastasis of mouse neuroblastoma.
Yoshizawa J; Mizuno R; Yoshida T; Hara A; Ashizuka S; Kanai M; Kuwashima N; Kurobe M; Yamazaki Y
J Surg Res; 2000 Sep; 93(1):82-7. PubMed ID: 10945947
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis can be reduced without significant reduction of tumor growth.
Svensson A; Bäckman U; Fuchs D; Christofferson R; Azarbayjani F
Anticancer Res; 2007; 27(6B):3883-9. PubMed ID: 18225546
[TBL] [Abstract][Full Text] [Related]
8. TNP-470 antiangiogenic therapy for advanced murine neuroblastoma.
Nagabuchi E; VanderKolk WE; Une Y; Ziegler MM
J Pediatr Surg; 1997 Feb; 32(2):287-93. PubMed ID: 9044139
[TBL] [Abstract][Full Text] [Related]
9. The angiogenesis inhibitor tnp-470 effectively inhibits human neuroblastoma xenograft growth, especially in the setting of subclinical disease.
Shusterman S; Grupp SA; Barr R; Carpentieri D; Zhao H; Maris JM
Clin Cancer Res; 2001 Apr; 7(4):977-84. PubMed ID: 11309349
[TBL] [Abstract][Full Text] [Related]
10. The bisphosphonate, zoledronic acid reduces experimental neuroblastoma growth by interfering with tumor angiogenesis.
Bäckman U; Svensson A; Christofferson RH; Azarbayjani F
Anticancer Res; 2008; 28(3A):1551-7. PubMed ID: 18630510
[TBL] [Abstract][Full Text] [Related]
11. CHS 828 inhibits neuroblastoma growth in mice alone and in combination with antiangiogenic drugs.
Svensson A; Bäckman U; Jonsson E; Larsson R; Christofferson R
Pediatr Res; 2002 May; 51(5):607-11. PubMed ID: 11978885
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effect of the angiogenesis inhibitor TNP-470 on human digestive organ malignancy.
Konno H
Cancer Chemother Pharmacol; 1999; 43 Suppl():S85-9. PubMed ID: 10357565
[TBL] [Abstract][Full Text] [Related]
13. Angiogenesis inhibitor, TNP-470, suppresses growth of peritoneal disseminating foci.
Yoshikawa T; Yanoma S; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Noguchi Y
Hepatogastroenterology; 2000; 47(31):298-302. PubMed ID: 10690624
[TBL] [Abstract][Full Text] [Related]
14. A novel animal model for hemangiomas: inhibition of hemangioma development by the angiogenesis inhibitor TNP-470.
Liekens S; Verbeken E; Vandeputte M; De Clercq E; Neyts J
Cancer Res; 1999 May; 59(10):2376-83. PubMed ID: 10344747
[TBL] [Abstract][Full Text] [Related]
15. Angiogenesis inhibitor TNP-470 inhibits human breast cancer osteolytic bone metastasis in nude mice through the reduction of bone resorption.
Sasaki A; Alcalde RE; Nishiyama A; Lim DD; Mese H; Akedo H; Matsumura T
Cancer Res; 1998 Feb; 58(3):462-7. PubMed ID: 9458090
[TBL] [Abstract][Full Text] [Related]
16. Malignant progression and blockade of angiogenesis in a murine transgenic model of neuroblastoma.
Chesler L; Goldenberg DD; Seales IT; Satchi-Fainaro R; Grimmer M; Collins R; Struett C; Nguyen KN; Kim G; Tihan T; Bao Y; Brekken RA; Bergers G; Folkman J; Weiss WA
Cancer Res; 2007 Oct; 67(19):9435-42. PubMed ID: 17909053
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic efficacy of the angiogenesis inhibitor O-(chloroacetyl-carbamoyl) fumagillol (TNP-470; AGM-1470) for human anaplastic thyroid carcinoma in nude mice.
Hama Y; Shimizu T; Hosaka S; Sugenoya A; Usuda N
Exp Toxicol Pathol; 1997 Aug; 49(3-4):239-47. PubMed ID: 9314059
[TBL] [Abstract][Full Text] [Related]
18. Regression of metastatic liver tumors in rats treated with angiogenesis inhibitor TNP-470: occurrence of apoptosis and necrosis.
Ahmed MH; Arai T; Konno H; Nahar L; Tanaka T; Izumiyama N; Takubo K; Nakamura S; Baba S
Jpn J Cancer Res; 1997 Oct; 88(10):977-81. PubMed ID: 9414660
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis inhibitor TNP-470 (AGM-1470) potently inhibits the tumor growth of hormone-independent human breast and prostate carcinoma cell lines.
Yamaoka M; Yamamoto T; Ikeyama S; Sudo K; Fujita T
Cancer Res; 1993 Nov; 53(21):5233-6. PubMed ID: 7693335
[TBL] [Abstract][Full Text] [Related]
20. Treatment of metastatic liver tumors by intermittent repetitive injection of an angiogenesis inhibitor using an implantable port system in a rabbit model.
Kuwata Y; Hirota S; Sako M
Kobe J Med Sci; 1997 Apr; 43(2):83-98. PubMed ID: 9385787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
